An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis

Patient Education and Counseling

Volumn 86, Issue 3, 2012, Pages 329-334

  Martin, Richard W ^a   Brower, Matthew E ^b   Geralds, Alexander ^a   Gallagher, Patience J ^b   Tellinghuisen, Donald J ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b CALVIN COLLEGE   (United States)

Author keywords

Decision making; Informed choice; Leaflets; Medication; Risk communication

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ACCURACY; ADULT; ARTICLE; COLLEGE STUDENT; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DISEASE COURSE; EXPERIMENTAL DESIGN; FACTORIAL DESIGN; FEMALE; GIST RECALL; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; PATIENT SATISFACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RECALL BIAS; RHEUMATOID ARTHRITIS; SINGLE BLIND PROCEDURE; STRUCTURAL JOINT DAMAGE; VALIDITY; VERBAL COMMUNICATION; VERBATIM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHOICE BEHAVIOR; COMMUNICATION; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84858082574     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2011.06.001     Document Type: Article

References (46)

1. Wennberg, John E. Tracking medicine: a researcher's quest to understand health care 2010, Oxford University Press, Oxford, p. 3-13.
2. Kazi S., Tillman M., Miller A.S. PQRI now includes RA measures group. Rheumatologist 2009, May.
3. Schmajuk G., Trivedi A.N., Solomon D.H., Yelon E., Trupin L., Chakravarty E.F., et al. Receipt of disease modifying antirheumatic drugs among patients with rheumatoid arthritis in medicare. Managed care plans 2011, 305:480-486.
4. Hochberg M.C., Silman A.J., Smolen J.S., Weinblatt M.E., Weisman M.H. Rheumatology 2008, Mosby, Philadelphia. 4th ed.
5. Donahue K.E., Gartlehner G., Jonas D.E., Lux L.J., Thieda P., Jonas B.L., et al. Systematic review: comparative effectiveness and harms for disease modifying anti-rheumtic drugs for rheumatoid arthritis. Ann Intern Med 2008, 148:124-134.
6. Fautrel B., Guillemin F., Meyer O., DeBandt M., Berthelot J.M., Flipo R.M., et al. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences. Arthritis Rheum 2009, 61:425-434.
7. Nestoriuc Y., Orav E.J., Liang M.H., Horne R., Barsky A.J. Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medications. Arthritis Rheum 2010, 62:791-799.
8. Constantinescu F., Goucher S., Weinstein A., Smith W., Fraenkel L. Understanding why rheumatoid arthritis patient treatment preferences differ by race. Arthritis Rheum 2009, 61:413-418.
9. Sharp J.T., Strand V., Leung H., Hurley F., Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum 2000, 43:495-505.
10. Blumenauer B., Judd M., Wells G., Burls A., Cranney A., Hochberg M., et al. Infliximab for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev 2002, (3):CD003785.
11. Mertens M., Singh J.A. Anakinra for rheumatoid arthritis. Cochrane Database Syst Rev 2009, (1):CD005121.
12. Navarro-Sarabia F., Ariza-Ariza R., Hernandez-Cruz B., Villanueva I. Adalimumab for treating rheumatoid arthritis. Cochrane Database Syst Rev 2005, (3):CD005113.
13. Bathon J.M., Martin R.W., Fleischmann R.M., Tesser J.R., Schiff M.H., Keystone E.C., et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000, 343:1586-1593.
14. Nair N., Strecher V., Fagerlin A., Resnicow K., Murphy S.A., Little R., et al. Screening Experiments and the use of factorial designs in behavioral intervention research. Am J Public Health 2008, 98:1354-1359.
15. Stein H.A., Slatt B.J., Stein R.M. The ophthalmic assistant: a guide for ophthalmic medical personnel 2000, Mosby, St. Louis, p. 138-9. 7th ed.
16. Martin R.W., Bader L.A., Head A.J., Turbergen E.J., Holmes-Rovner M. Identifying patients who need low literacy materials to support anti-rheumatic drug decision making. Arthritis Rheum 2007, 56:S109.
17. Edwards A., Elwyn G., Hood K., Robling M., Atwell C., Holmes-Rovner M., et al. The development of COMRADE - a patient-based outcome measure to evaluate the effectiveness of risk communication and treatment decision making in consultations. Patient Educ Couns 2003, 50:311-322.
18. Reyna V.F. How people make decisions that involve risk: a dual processing approach. Curr Dir Psychol Sci 2004, 12:60-66.
19. SPSS V 16 2007, SPSS Inc., Chicago.
20. Schultz K.F., Altman D.G., Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010, 152(11):1-8. for the CONSORT Group.
21. Bekker H.L. The loss of reason in patient decision aid research: do checklists damage the quality of informed choice interventions?. Patient Educ Couns 2010, 78:357-364.
22. Chapman G.B. The psychology of medical decision making 2007, Blackwell Handbook of Judgement and Decision Making, p. 585-603.
23. Kahneman D., Tversky A. Prospect theory: an analysis of decision under risk. [book auth.] Kahneman, D, Tversky, A, Choices, values and frames 2000, Cambridge University Press, Cambridge.
24. Payne J.W., Bettman J.R., Johnson E.J. The adaptive decision maker 1993, Cambridge University Press, New York, p. 171-91.
25. Reyna V.F. A theory of medical decision making and health: fuzzy trace theory. Med Decis Making 2008, 28:850-865.
26. Payne J.W., Bettman J.R., Johnson E.J. The adaptive decision maker 1993, Cambridge University Press, New York, p. 22-9.
27. Galesic M., Cesario J., Gigerenzer G. Take the best approach to decision aids. Oral presentation at the 30th annual meeting of the society for medical decision making 2008.
28. Ubel P.A. Is information always a good thing? helping patients make " good" decisions. Med Care 2002, 40:39-44.
29. Martin R.W., Raykov T., Head A.J., Feichtner J., Holmes-Rovner M. Rheumatoid arthritis disease modifying anti-rheumatic drug knowledge profile: development and validation. Arthritis Rheum 2006, 54:S700.
30. Martin R.W., Swartz T., McIntyre B., Holmes-Rovner M. Effectiveness of disease modifying anti-rheumatic drug risk communication in rheumatoid arthritis. Arthritis Rheum 2006, 54:S369.
31. Lipkus I.M., Samsa G., Rimer B.K. General performance on a numeracy scale among highly educated samples. Med Decis Making 2001, 21:37-44.
32. Galesic M., Gigerenzer G., Straubinger N. Natural frequencies help older adults and people with low numeracy to evaluate medical screening tests. Med Decis Making 2009, 29:368-371.
33. Woloshin S., Schwartz L.M., Welch H.G. The effectiveness of a primer to help people understand risk: two randomized trials in distinct populations. Ann Intern Med 2007, 146:256-265.
34. Gigerenzer G. The psychology of good judgment: frequency formats and simple algorithms. Med Decis Making 1996, 16:273-280.
35. Galesic M., Garcia-Retamero R., Gigerenzer G. Using icon arrays to communicate medical risks: overcoming low numeracy. Health Psychol 2009, 28:210-216.
36. Schwartz L.M., Woloshin S., Welch H.G. Using a drug facts box to communicate drug benefits and harms: two randomized trials. Ann Intern Med 2009, 150:516-527.
37. Zikmund-Fisher B.J., Ubel P.A., Smith D.M., Derry H.A., McClure J.B., Stark A., et al. Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs. Patient Educ Couns 2008, 73:209-214.
38. Winterbottom A., Bekker H.L., Conner M., Mooney A. Does narrative information bias individual's decision making?. Soc Sci Med 2008, 67:2079-2088.
39. Peters E., Dieckmann N., Dixon A., Hibbard J.H. Less is more in presenting quality information to consumers. Med Care Res Rev 2007, 10:1-22.
40. Ubel P.A., Smith D.M., Zikmund-Fisher B.J., Derry H.A., McClure J., Stark A., et al. Testing whether decision aids introduce cognitive biases: results of a randomized trial. Patient Educ Couns 2010, 80:158-163.
41. Edwards A., Elwyn G., Mulley A. Explaining risks: turning numerical data into meaningful. Br Med J 2002, 324:827-830.
42. Liu Chiung-ju, Kemper S., McDowd J. The use of illustration to improve older adults' comprehension of health-related information: is it helpful?. Patient Educ Couns 2009, 76:283-288.
43. Martin R.W., Gallagher P.J., Eggebeen A.T., Head A.J. A decision aid for rheumatoid arthritis patients considering methotrexate therapy. Arthritis Rheum 2009, 60:S324.
44. Vohs K.D., Mead N.L., Goode M.R. The psychological consequences of money. Science 2006, 314:1154-1156.
45. Baumeister R.F., Vohs K.D., DeWall C.N., Zhang L. How emotion shapes behavior: feedback, anticipation, and reflection, rather than direct causation. Pers Soc Psychol Rev 2007, 11:167-203.
46. International patient decision aid collaboration: what are patient decision aids? ; 2009. http://ipdas.ohri.ca/what.html.